Supernus Pharmaceuticals Inc (SUPN)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1550 E GUDE DR ROCKVILLE, MD 20850

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.

Data based on most recent fiscal year report
Market Cap1.295 Billion Shares Outstanding52.46 Million Avg Volume772.317 Thousand
1-Yr BETA vs S&P TR1.465 Current Ratio3.06 Quick Ratio2.9
View SEC Filings from SUPN instead.

View recent insider trading info

Funds Holding SUPN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SUPN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KHATTAR JACK A. PRESIDENT, CEO

  • Officer
  • Director
1,547,291 2019-12-26 4

BARRIS PETER J

  • Director
849,527 2019-12-26 0

BASKETT FOREST

  • 10% Owner
2,052,454 2019-12-24 0

SANDELL SCOTT D

  • 10% Owner
2,052,454 2019-12-24 0

MATUSHANSKY IGOR CHIEF MEDICAL OFFICER

  • Officer
58,898 2019-12-19 1

LENGAUER CHRISTOPH

  • Director
0 2019-12-18 1

BIGHAM MICHAEL

  • Director
419,417 2019-10-04 0

PATRICK GREGORY S SR. VP,CHIEF FINANCIAL OFFICER

  • Officer
45,682 2019-07-31 3

SIEBERT JOHN M

  • Director
55,742 2019-06-20 4

GEMAYEL GEORGES

  • Director
14,090 2019-06-19 1

HUDSON FREDERICK M.

  • Director
0 2019-06-18 1

BARRETT M JAMES

  • Director
0 2019-05-30 0

PINSCHEWER DAVID CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-04-17 1

BHATT PADMANABH P. SR. VP OF IP, CSO

  • Officer
0 2019-02-22 1

NEWHALL CHARLES W III

  • Director
92,298 2019-02-22 1

BARLOW CARROLEE

  • Director
0 2019-02-22 1

SCHWABE STEFAN K.F. EXECUTIVE VP R&D, CMO

  • Officer
1,967 2018-06-18 0

VAUGHN VICTOR SR. VP OF SALES & MARKETING

  • Officer
9,344 2018-04-18 0

BRYAN JONES W. SR. VICE PRES., BD & LICENSING

  • Officer
No longer subject to file 2018-02-13 0

NUERGE WILLIAM A.

  • Director
23,750 2017-06-13 0

KOLLURI KRISHNA KITTU

  • 10% Owner
5,215,128 2016-12-19 0

NEW ENTERPRISE ASSOCIATES 11 LP

  • 10% Owner
No longer subject to file 2015-11-11 0

NEA PARTNERS 11 LP

  • 10% Owner
No longer subject to file 2015-11-11 0

ORBIMED ADVISORS LLC

ISALY SAMUEL D

ORBIMED CAPITAL GP II LLC

  • 10% Owner
No longer subject to file 2013-02-12 0

MARTIN TAMI TILLOTSON VP OF REGULATORY AFFAIRS

  • Officer
50,625 2012-12-12 0

NEW ENTERPRISE ASSOCIATES 11 LP

NEA PARTNERS 11 LP

NEA 11 GP, LLC

BARRIS PETER J

BASKETT FOREST

DRANT RYAN D

KOLLURI KRISHNA KITTU

KRAMLICH C RICHARD

PERRY MARK W

SANDELL SCOTT D

  • 10% Owner
10,641,250 2012-05-04 0

SHEFFERY MICHAEL B

  • Director
6,099,996 2012-05-04 0

ABINGWORTH MANAGEMENT LTD

  • 10% Owner
3,600,000 2012-05-04 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

2019-12-26 G 1,100 d 464,041 1,547,291.00 direct

KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

2019-12-26 G 1,100 d 461,841 1,547,291.00 direct

KHATTAR JACK A. - Director - Officer PRESIDENT, CEO

2019-12-26 G 1,100 d 462,941 1,547,291.00 direct

KHATTAR JACK A. - Director - Officer PRESIDENT, CEO by son

2019-12-26 G 1,100 a 4,000 1,547,291.00 indirect
Click here to report any possible errors with this stock listing.

Elevate your investments